Key result
Preoperative aspirin is linked to ~77% higher RBC transfusion odds but not more bleeding re-operations.
Why the study?
Does preoperative aspirin use within 5 days of surgery increase bleeding and transfusion requirements in patients undergoing cardiac surgery?
Cohort (n=728)
No
Does preoperative aspirin use within 5 days of surgery increase bleeding and transfusion requirements in patients undergoing cardiac surgery?
Preoperative aspirin within 5 days of cardiac surgery increases the likelihood of RBC transfusion but does not significantly increase major bleeding complications like re-operation or chest tube drainage.
Answers are grounded in this paper and cite their sources.
May increase transfusion risk without major bleeding; leaves open need for randomized confirmation before changing perioperative aspirin guidance.
OBJECTIVE: Despite evidence that preoperative aspirin improves outcomes in cardiac surgery, recommendations for aspirin use are inconsistent due to aspirin's anti-platelet effect and concern for bleeding. The purpose of this study was to investigate preoperative aspirin use and its effect on bleeding and transfusion in cardiac surgery. METHODS: This retrospective study involved consecutive patients (n=1571) who underwent CABG, valve, or combined CABG and valve surgery at a single center between March 2007 and July 2012. Of all patients, 728 met the inclusion criteria and were divided into two groups: those using (n=603) or not using (n=125) aspirin within 5 days of surgery. Data were collected on chest tube drainage, re-operation for bleeding, and transfusion of red blood cells (RBCs), fresh frozen plasma (FFP), and platelets. RESULTS: No significant difference was observed between the two groups in chest tube drainage or re-operation for bleeding. An increase in patients transfused with RBCs was observed in the aspirin group (61.9 vs 51.2%, adjusted OR 1.77, p=0.027); however, among those transfused RBCs, no significant difference in mean units transfused or massive transfusion was observed. No significant difference was seen in transfusion requirement of FFP or platelets. CONCLUSIONS: In patients undergoing CABG, valve, or combined CABG/valve surgery, preoperative aspirin, within 5 days of surgery, was associated with an increased probability of receiving an RBC transfusion. Preoperative aspirin was not associated with an increase in chest tube drainage, re-operation for bleeding complications, or transfusion of FFP or platelets.
No takes yet. Share an insight, caveat, or question.
Goldhammer et al. (2015) conducted a cohort in Cardiac surgery (CABG, valve, or combined) (n=728). Preoperative aspirin vs. No preoperative aspirin was evaluated on Red blood cell (RBC) transfusion (OR 1.77, 95% CI 1.07, 2.95, p=0.027). Preoperative aspirin use within 5 days of cardiac surgery was associated with an increased probability of receiving a red blood cell transfusion but not with increased re-operation for bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: